Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03846505Phase 2Completed
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Oxytocin + ABCT with Placebo + ABCT (2 arms). Primary endpoints: Change in Percent Days Abstinent at 12 weeks, Change in Relationship Functioning at 12 weeks and 1 more. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03846505.